Macitentan | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Macitentan
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Macitentan

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 12 USDMF, 6 EU WC, 1 KDMF, 9 NDC API, 25 Listed Suppliers, $ API Reference Price

31 API Suppliers
12 USDMF
6 EU WC
1 KDMF
9 NDC API
25 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

26 FDF Dossiers, 8 FDA Orange Book, 5 Europe, 2 Canada, 4 Australia, 1 South Africa, 6 Listed Dossiers

26 FDF Dossiers
8 FDA Orange Book
5 Europe
2 Canada
4 Australia
1 South Africa
6 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 4 DKSH, 1 Pharm-RX Chemical, 3 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 2 Actylis, 1 Aeon Procare, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 5 Corel Pharma Chem, 5 DFE Pharma, 10 Gangwal Chemicals, 3 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 20 Kerry, 10 Microlex e.U, 1 Nanjing Bold Chemical, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 11 Roquette, 6 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 3 Vasa Pharmachem

1 Rochem International Inc
1 SPI Pharma
4 DKSH
1 Pharm-RX Chemical
3 Faran Shimi Pharmaceutical
1 Boai NKY Pharmaceuticals Ltd
4 Gangwal Healthcare
3 Nanjing Well Pharmaceutical
2 Actylis
1 Aeon Procare
3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
11 BASF
5 Corel Pharma Chem
5 DFE Pharma
10 Gangwal Chemicals
3 Ideal Cures Pvt Ltd
1 Ingredion Pharma Solutions
20 Kerry
10 Microlex e.U
1 Nanjing Bold Chemical
2 Novo Excipients
3 Pharmatrans-Sanaq
3 Pluviaendo
3 Prachin Chemical
11 Roquette
6 Seppic
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
11 Sigachi Industries
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Fillers, Diluents & Binders, 21 Coating Systems & Additives, 17 Solubilizers, 16 Thickeners and Stabilizers, 15 Disintegrants & Superdisintegrants, 15 Direct Compression, 14 Granulation, 12 Lubricants & Glidants, 11 Controlled & Modified Release, 10 Parenteral, 8 Co-Processed Excipients, 7 Film Formers & Plasticizers, 6 Topical, 5 Emulsifying Agents, 4 Rheology Modifiers, 3 API Stability Enhancers, 3 Taste Masking, 2 Surfactant & Foaming Agents, 2 Coloring Agents, 2 Chewable & Orodispersible Aids

43 Fillers, Diluents & Binders
21 Coating Systems & Additives
17 Solubilizers
16 Thickeners and Stabilizers
15 Disintegrants & Superdisintegrants
15 Direct Compression
14 Granulation
12 Lubricants & Glidants
11 Controlled & Modified Release
10 Parenteral
8 Co-Processed Excipients
7 Film Formers & Plasticizers
6 Topical
5 Emulsifying Agents
4 Rheology Modifiers
3 API Stability Enhancers
3 Taste Masking
2 Surfactant & Foaming Agents
2 Coloring Agents
2 Chewable & Orodispersible Aids

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 1 STOCK RECAP #PipelineProspector, 40 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
1 STOCK RECAP #PipelineProspector
40 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 3 Finished Drug Prices, 8 Annual Reports

1 US Medicaid Prescriptions
3 Finished Drug Prices
8 Annual Reports

MARKET PLACE

7 APIs, 3 FDF Dossiers

7 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 US Patents, 3 Health Canada Patents

5 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ API Ref.Price (USD/KG) : 12,390 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

5 All

01 5ACTELION

filter Patent Number Reset all filters

5 All

01 17094781

02 18268847

03 18367685

04 19265762

05 110946015

filter API Patent Reset all filters

5 All

01 1Y

02 4Blank

filter FDF Patent Reset all filters

5 All

01 4Y

02 1Blank

filter Expiration Date Reset all filters

5 All

01 12025-12-05

02 12026-09-11

03 12027-05-29

04 12028-10-04

05 12029-04-18

Product Main Page

01

ACTELION

The Generic Rx Session

Not Confirmed

ACTELION

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-04-18

US Patent Number : 8268847

Drug Substance Claim :

Drug Product Claim :

Application Number : 204410

Patent Use Code : U-1446

Delist Requested :

Patent Use Description : METHOD OF TREATING PUL...

Patent Expiration Date : 2029-04-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ACTELION

The Generic Rx Session

Not Confirmed

ACTELION

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-05-29

US Patent Number : 9265762

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204410

Patent Use Code : U-1820

Delist Requested :

Patent Use Description : METHOD OF TREATING PUL...

Patent Expiration Date : 2027-05-29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ACTELION

The Generic Rx Session

Not Confirmed

ACTELION

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-09-11

US Patent Number : 10946015

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204410

Patent Use Code : U-1445

Delist Requested :

Patent Use Description : METHOD OF TREATING PUL...

Patent Expiration Date : 2026-09-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

ACTELION

The Generic Rx Session

Not Confirmed

ACTELION

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-10-04

US Patent Number : 8367685

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204410

Patent Use Code : U-1445

Delist Requested :

Patent Use Description : METHOD OF TREATING PUL...

Patent Expiration Date : 2028-10-04

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

ACTELION

The Generic Rx Session

Not Confirmed

ACTELION

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-12-05

US Patent Number : 7094781

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204410

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-12-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!